SCHEMBL185884

SCHEMBL185884

O=C(CC(F)(F)F)NC1CC1.O=C(O)NCc1ccc(Nc2ccc(Cl)cc2C(F)(F)F)cn1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 8/20 0.38
RAB9A P51151 3/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C19 P33261 1/20 0.36
P2RX7 Q99572 2/20 0.35
CNR1 P21554 2/20 0.35
LMNA P02545 1/20 0.35
FLT3 P36888 1/20 0.34
TP53 P04637 1/20 0.34
MAPT P10636 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
CRHR1 P34998 1/20 0.34
KDM4E B2RXH2 1/20 0.34
NPC1 O15118 1/20 0.34
ALDH1A1 P00352 1/20 0.34
HTT P42858 1/20 0.34
PAX8 Q06710 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL185747 0.90 CNR2 (0.39) CNR2RAB9ACYP1A2CYP2D6CYP2C19
SCHEMBL186629 0.89 HTR2A (0.39) CNR2RAB9ACYP1A2CYP2D6CYP2C19
SCHEMBL185393 0.87 CNR2 (0.42) CNR2RAB9ACYP1A2CYP2D6CYP2C19
Trifluoroacetic Acid SCHEMBL14856625 0.84 CNR2 (0.40) CNR2RAB9ACYP1A2CYP2D6CYP2C19
SCHEMBL185320 0.84 GAA (0.36) CNR2RAB9ACYP1A2CYP2D6CYP2C19
SCHEMBL2809043 0.80 CNR2 (0.38) CNR2RAB9ACYP1A2CYP2D6CYP2C19
SCHEMBL2811071 0.79 RAB9A (0.44) CNR2RAB9ACYP1A2CYP2D6CYP2C19
SCHEMBL185728 0.78 IRAK4 (0.39) CNR2CNR1
SCHEMBL185476 0.77 KIT (0.40) CNR2P2RX7CNR1FLT3
SCHEMBL2809946 0.77 CNR2 (0.39) CNR2RAB9ACYP1A2CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2401256-B1 Compounds as bradykinin B1 antagonists BOEHRINGER INGELHEIM INT (DE) 2013-04-17 EP disclosed
EP-2401256-A1 COMPOUNDS AS BRADYKININ B1 ANTAGONISTS Boehringer Ingelheim International GmbH (DE) 2012-01-04 EP disclosed
WO-2010097372-A1 COMPOUNDS AS BRADYKININ B1 ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-09-02 WO disclosed